Publications

"In 2018, nearly 89% of the estimated 20.2 million Americans with a substance use disorder (SUD) did not receive specialized treatment for their condition—a disparity known as the “treatment gap”.

Cannabis is one of the most widely used psychoactive substances in Canada.

The complex relationship between cannabis use and mental disorders has garnered significant attention as a public health issue

This is the first in a series of reports, published by the Canadian Centre on Substance Use and Addiction (CCSA), that reviews the effects of cannabis use on various aspects of human functioning and development.

The consumption of alcohol, tobacco and other drugs is a significant cause of preventable disease and illness in Australia. There is a wide range of data sources available that contribute to our understanding of alcohol, tobacco and other drug use. 

EFFECTIVENESS OF SCREENING AND BRIEF INTERVENTIONS

On 16 September 2014, European Union (EU) the Member States, represented by the Committee on National Alcohol Policy and Action (CNAPA), endorsed the Action Plan on Youth Drinking and on Heavy Episodic Drinking (Binge Drinking) (2014-2016). 

The need to reduce alcohol-related harms has been recognized by the 2010 World Health Organization (WHO) Global Strategy to Reduce the Harmful Use of Alcohol (adopted by the Sixty-third World Health Assembly), the United Nations Sustainable Development Goals, the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, and the Pan American Health Organization (PAHO) Plan of Action to Reduce the Harmful Use o

The adverse impact of alcohol consumption include the negative consequences of drinking on individuals other than the drinkers themselves, including both health and social problems.  Alcohol’s harm to others (HTO) is an interactional occurrence at the level of individuals and their relationships and is determined from the perspective of those affected by the drinker rather than from the perspective of the drinker or the society.

This volume provides a serious examination of substance use prevention research and practices as components of the continuum from health promotion through to prevention and health care in sub-groups and in the general population.

Abstract | Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse.

The Education and Training Unit of the National Dangerous Drugs Control Board (NDDCB) organised training on “UTC 06- Case Management for Addiction Professionals and UTC 07- Crisis Intervention for Addiction Professionals” for 28 staff members of the NDDCB which was held on 17th – 19th December 2019 at NDDCB Auditorium.

The stigma associated with drug use and addictive behaviors affects in a transverse way in people's lives, making an impact on physical and mental health, the ability to find and maintain a job, to find and maintain a home, in their relationships social and self-concept. On the other hand, the stigma delays the search for adequate treatment and is in itself a barrier to access and stay in treatments.

Drinking alcohol increases the risk of mouth cancer, pharyngeal (upper throat) cancer, oesophageal (food pipe) cancer, laryngeal (voice box) cancer, breast cancer, bowel cancer and liver cancer.

Tobacco is the only legal drug that kills many of its users when used exactly as intended by manufacturers. WHO has estimated that tobacco use (smoking and smokeless) is currently responsible for the death of about six million people across the world each year with many of these deaths occurring prematurely. This total includes about 600,000 people are also estimated to die from the effects of second-hand smoke.

Abstract: Background Globally, an estimated 15·6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the association between injecting drug use (IDU) in young people and rates of injecting and sexual risk behaviours at the country level.

The material promotes the development of intervention strategies for a comprehensive and networked approach to problematic substance use in areas of deprivation of liberty. Encouraging the participation of detainees, their families, prison service benchmarks and the community at large. It starts from a rights and health promotion approach, developing a comprehensive and articulated work with the different actors involved.

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. 

The analysis presented in the report examines topics such as the links between drugs and other crimes, the licit economy and society more generally as well as the processes and players involved in the trade, from production and trafficking to distribution.

Children are the foundation of the United States, and supporting them is a key component of building a successful future. However, millions of children face health inequities that compromise their development, well-being, and long-term outcomes, despite substantial scientific evidence about how those adversities contribute to poor health.

In order to appropriately address the concerning global levels of substance use and substance use disorders, it is vital that staff are trained to deliver evidence-based treatment.

At the start of November 2019, the Education and Training Unit of the National Dangerous Drugs Control Board conducted training on Basic Counseling Skills for 28 staff members of the NDDCB.